Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diagnostic and prognostic biomarkers in cholangiocarcinoma
Rocı́o I.R. Macı́as, Miroslaw Kornek, Pedro M. Rodrigues, et al.
Liver International (2019) Vol. 39, Iss. S1, pp. 108-122
Open Access | Times Cited: 104

Showing 1-25 of 104 citing articles:

Molecular targeted therapies: Ready for “prime time” in biliary tract cancer
Ángela Lamarca, Jorge Barriuso, Mairéad G. McNamara, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 1, pp. 170-185
Open Access | Times Cited: 298
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry
Laura Izquierdo‐Sánchez, Ángela Lamarca, Adelaida La Casta, et al.
Journal of Hepatology (2022) Vol. 76, Iss. 5, pp. 1109-1121
Open Access | Times Cited: 218
Biomarkers for Hepatobiliary Cancers
Jean–Charles Nault, Augusto Villanueva
Hepatology (2020) Vol. 73, Iss. S1, pp. 115-127
Closed Access | Times Cited: 148
Current epidemiology of cholangiocarcinoma in Western countries
Mathew Vithayathil, Shahid A. Khan
Journal of Hepatology (2022) Vol. 77, Iss. 6, pp. 1690-1698
Closed Access | Times Cited: 106
Current standards and future perspectives in adjuvant treatment for biliary tract cancers
Ángela Lamarca, Julien Edeline, Mairéad G. McNamara, et al.
Cancer Treatment Reviews (2019) Vol. 84, pp. 101936-101936
Open Access | Times Cited: 100
Patients with Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease Diagnosis
Ainhoa Lapitz, Ander Arbelaiz, Colm J. O’Rourke, et al.
Cells (2020) Vol. 9, Iss. 3, pp. 721-721
Open Access | Times Cited: 80
Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures
María Arechederra, María Rullán, Irene Amat, et al.
Gut (2021) Vol. 71, Iss. 6, pp. 1141-1151
Open Access | Times Cited: 62
Plasmon‐Enhanced Single Extracellular Vesicle Analysis for Cholangiocarcinoma Diagnosis
Mi Ho Jeong, Taehwang Son, Yoo Keung Tae, et al.
Advanced Science (2023) Vol. 10, Iss. 8
Open Access | Times Cited: 29
Prognostic and Predictive Molecular Markers in Cholangiocarcinoma
Sandra Pavicevic, Sophie Reichelt, Deniz Uluk, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 1026-1026
Open Access | Times Cited: 31
Pilot Multi-Omic Analysis of Human Bile from Benign and Malignant Biliary Strictures: A Machine-Learning Approach
Jesús Urmán, José M. Herranz, Iker Uriarte, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1644-1644
Open Access | Times Cited: 48
Mitogen-Activated Protein Kinases (MAPKs) and Cholangiocarcinoma: The Missing Link
Chaobo Chen, Leonard J. Nelson, Matías A. Ávila, et al.
Cells (2019) Vol. 8, Iss. 10, pp. 1172-1172
Open Access | Times Cited: 47
Next-Generation Biomarkers for Cholangiocarcinoma
Pedro M. Rodrigues, Arndt Vogel, Marco Arrese, et al.
Cancers (2021) Vol. 13, Iss. 13, pp. 3222-3222
Open Access | Times Cited: 34
Circular RNAs in cholangiocarcinoma
Wenwei Liao, Qingbo Feng, Huixian Liu, et al.
Cancer Letters (2022) Vol. 553, pp. 215980-215980
Closed Access | Times Cited: 23
Unveiling the prognostic role of blood inflammatory indexes in a retrospective cohort of patients undergoing liver resection for intrahepatic cholangiocarcinoma
Flavio Milana, Michela Anna Polidoro, Cristiana Soldani, et al.
International Journal of Surgery (2024) Vol. 110, Iss. 11, pp. 7088-7096
Open Access | Times Cited: 5
Exosomal circRNAs: new players in the field of cholangiocarcinoma
Corentin Louis, Matthis Desoteux, Cédric Coulouarn
Clinical Science (2019) Vol. 133, Iss. 21, pp. 2239-2244
Open Access | Times Cited: 37
Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options
Nicola Personeni, Ana Lleò, Tiziana Pressiani, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3370-3370
Open Access | Times Cited: 36
Molecular Pathogenesis and Regulation of the miR-29-3p-Family: Involvement of ITGA6 and ITGB1 in Intra-Hepatic Cholangiocarcinoma
Yuto Hozaka, Naohiko Seki, Takako Tanaka, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2804-2804
Open Access | Times Cited: 30
Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know
Jacek Baj, Łukasz Bryliński, Filip Woliński, et al.
Cancers (2022) Vol. 14, Iss. 6, pp. 1493-1493
Open Access | Times Cited: 19
Performance evaluation of the Elecsys PIVKA‐II and Elecsys AFP assays for hepatocellular carcinoma diagnosis
Henry Lik‐Yuen Chan, Arndt Vogel, Thomas Berg, et al.
JGH Open (2022) Vol. 6, Iss. 5, pp. 292-300
Open Access | Times Cited: 19
Comprehensive landscape and oncogenic role of extrachromosomal circular DNA in malignant biliary strictures
Zhuo Cheng, Xuanmei Luo, Wenzheng Liu, et al.
Cell & Bioscience (2025) Vol. 15, Iss. 1
Open Access
Analysis of bile acid profile in plasma to differentiate cholangiocarcinoma from benign biliary diseases and healthy controls
Xiaofen Zhang, Ziyao Yang, Ziyu Shi, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2020) Vol. 205, pp. 105775-105775
Closed Access | Times Cited: 29
Current and New Biomarkers for Early Detection, Prognostic Stratification, and Management of Gallbladder Cancer Patients
Patricia García, Ángela Lamarca, Javier Díaz‐Ferrer, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3670-3670
Open Access | Times Cited: 28
Phosphatidylcholine in bile‐derived small extracellular vesicles as a novel biomarker of cholangiocarcinoma
Ryuta Muraki, Yoshifumi Morita, Shinya Ida, et al.
Cancer Medicine (2023) Vol. 12, Iss. 12, pp. 13007-13018
Open Access | Times Cited: 10
A new biomarker panel for differential diagnosis of cholangiocarcinoma: Results from an exploratory analysis
Bruno Köhler, Marta Bes, Henry Lik‐Yuen Chan, et al.
The International Journal of Biological Markers (2024) Vol. 39, Iss. 2, pp. 107-117
Open Access | Times Cited: 3
A Novel Serum Metabolomic Profile for the Differential Diagnosis of Distal Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma
Rocı́o I.R. Macı́as, Luis Muñoz‐Bellvís, Anabel Sánchez-Martín, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1433-1433
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top